331 related articles for article (PubMed ID: 37745036)
1. Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review).
Qu Y; Li D; Liu W; Shi D
Exp Ther Med; 2023 Oct; 26(4):482. PubMed ID: 37745036
[TBL] [Abstract][Full Text] [Related]
2. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
3. T helper 17 cell population in lupus erythematosus.
Bălănescu P; Bălănescu E; Tănăsescu C; Nicolau A; Tănăsescu R; Grancea C; Vagu C; Ruţă S; Bleoţu C
Rom J Intern Med; 2010; 48(3):255-9. PubMed ID: 21528751
[TBL] [Abstract][Full Text] [Related]
4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
5. The star target in SLE: IL-17.
Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjögren's syndrome patients with dry eye disease.
Peng X; Lu Y; Wei J; Lin T; Lu Q; Liu Q; Ting WJ
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):159-165. PubMed ID: 34596026
[TBL] [Abstract][Full Text] [Related]
8. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
9. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
[TBL] [Abstract][Full Text] [Related]
11. IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.
Farah Izati A; Wong KK; Che Maraina CH
Malays J Pathol; 2020 Dec; 42(3):333-347. PubMed ID: 33361714
[TBL] [Abstract][Full Text] [Related]
12. The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease.
Li M; Yang C; Wang Y; Song W; Jia L; Peng X; Zhao R
J Immunol; 2020 Oct; 205(7):1752-1762. PubMed ID: 32868411
[TBL] [Abstract][Full Text] [Related]
13. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of CCR6
Zhong W; Jiang Y; Ma H; Wu J; Jiang Z; Zhao L
Sci Rep; 2017 Oct; 7(1):12962. PubMed ID: 29021537
[TBL] [Abstract][Full Text] [Related]
15. Disabled-2 overexpression mediates immune suppression in systemic lupus erythematosus by modulating Treg/Th17 cell differentiation.
Zhang J; Chang L; Sun Y; Qin M; Wang X; Guo Y
Clin Exp Pharmacol Physiol; 2022 May; 49(5):596-607. PubMed ID: 35108421
[TBL] [Abstract][Full Text] [Related]
16. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.
Shin MS; Lee N; Kang I
Curr Opin Rheumatol; 2011 Sep; 23(5):444-8. PubMed ID: 21720245
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms near IL-21 gene associated with Th17 cytokines confer risk for systemic lupus erythematosus in Chinese Han population.
Meng Y; Xu H; Zhang S; Zhang J; Wang L; Tang H; Wu Y
Lupus; 2019 Mar; 28(3):406-413. PubMed ID: 30774014
[TBL] [Abstract][Full Text] [Related]
18. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
19. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study.
Tian J; Zhang D; Yao X; Huang Y; Lu Q
Ann Rheum Dis; 2023 Mar; 82(3):351-356. PubMed ID: 36241363
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
Yazdani MR; Aflaki E; Gholijani N
Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
